Incorporation of Biologically Active Ingredient Gallic Acid Into Nano-scale Lipid Vesicles

Nano-scale lipid vesicles or liposomes are extremely important lipid particles because of their unique properties and possible incorporation of various biologically active substances into their interior. Therefore, they can be used for numerous biomedical applications. Liposomes have the ability to...

Full description

Bibliographic Details
Main Authors: Nika Kucuk, Mateja Primozic, Zeljko Knez, Maja Leitgeb
Format: Article
Language:English
Published: AIDIC Servizi S.r.l. 2023-06-01
Series:Chemical Engineering Transactions
Online Access:https://www.cetjournal.it/index.php/cet/article/view/13409
_version_ 1827912185253199872
author Nika Kucuk
Mateja Primozic
Zeljko Knez
Maja Leitgeb
author_facet Nika Kucuk
Mateja Primozic
Zeljko Knez
Maja Leitgeb
author_sort Nika Kucuk
collection DOAJ
description Nano-scale lipid vesicles or liposomes are extremely important lipid particles because of their unique properties and possible incorporation of various biologically active substances into their interior. Therefore, they can be used for numerous biomedical applications. Liposomes have the ability to protect incorporated bioactive substances, thereby preserving their function. They have a significant advantage over various nanoparticles, as they can bind and transfer hydrophobic, hydrophilic, and amphiphilic compounds. The aim of the study was the synthesis of liposomes, suitable for the potential encapsulation of active ingredients for pharmaceutical and clinical purposes. Liposomes were prepared using a thin lipid film hydration method with glass beads. The synthesized liposomes were characterized by measuring the zeta potential to determine their stability, polydispersity index, and particle size. Furthermore, the biologically active ingredient gallic acid (GA) was incorporated into the lipid vesicles at different concentrations. The encapsulation efficiency of the active ingredient GA in liposomes and the in vitro release of the encapsulated bioactive component were studied using the dialysis technique. Synthesized nano-scale lipid vesicles were found to be stable, with an average size of 181.5 nm. The highest encapsulation efficiency (98.3%) and the highest percentage of released bioactive substance (38.3%) were obtained at 0.1 mg/mL of GA. GA-incorporated nano-scale lipid vesicles are promising as suitable carriers of bioactive ingredients for various therapeutic purposes.
first_indexed 2024-03-13T02:12:27Z
format Article
id doaj.art-cb5723ffd84b427d9b8ab88d746072f7
institution Directory Open Access Journal
issn 2283-9216
language English
last_indexed 2024-03-13T02:12:27Z
publishDate 2023-06-01
publisher AIDIC Servizi S.r.l.
record_format Article
series Chemical Engineering Transactions
spelling doaj.art-cb5723ffd84b427d9b8ab88d746072f72023-06-30T22:32:04ZengAIDIC Servizi S.r.l.Chemical Engineering Transactions2283-92162023-06-0110010.3303/CET23100087Incorporation of Biologically Active Ingredient Gallic Acid Into Nano-scale Lipid VesiclesNika KucukMateja PrimozicZeljko KnezMaja LeitgebNano-scale lipid vesicles or liposomes are extremely important lipid particles because of their unique properties and possible incorporation of various biologically active substances into their interior. Therefore, they can be used for numerous biomedical applications. Liposomes have the ability to protect incorporated bioactive substances, thereby preserving their function. They have a significant advantage over various nanoparticles, as they can bind and transfer hydrophobic, hydrophilic, and amphiphilic compounds. The aim of the study was the synthesis of liposomes, suitable for the potential encapsulation of active ingredients for pharmaceutical and clinical purposes. Liposomes were prepared using a thin lipid film hydration method with glass beads. The synthesized liposomes were characterized by measuring the zeta potential to determine their stability, polydispersity index, and particle size. Furthermore, the biologically active ingredient gallic acid (GA) was incorporated into the lipid vesicles at different concentrations. The encapsulation efficiency of the active ingredient GA in liposomes and the in vitro release of the encapsulated bioactive component were studied using the dialysis technique. Synthesized nano-scale lipid vesicles were found to be stable, with an average size of 181.5 nm. The highest encapsulation efficiency (98.3%) and the highest percentage of released bioactive substance (38.3%) were obtained at 0.1 mg/mL of GA. GA-incorporated nano-scale lipid vesicles are promising as suitable carriers of bioactive ingredients for various therapeutic purposes.https://www.cetjournal.it/index.php/cet/article/view/13409
spellingShingle Nika Kucuk
Mateja Primozic
Zeljko Knez
Maja Leitgeb
Incorporation of Biologically Active Ingredient Gallic Acid Into Nano-scale Lipid Vesicles
Chemical Engineering Transactions
title Incorporation of Biologically Active Ingredient Gallic Acid Into Nano-scale Lipid Vesicles
title_full Incorporation of Biologically Active Ingredient Gallic Acid Into Nano-scale Lipid Vesicles
title_fullStr Incorporation of Biologically Active Ingredient Gallic Acid Into Nano-scale Lipid Vesicles
title_full_unstemmed Incorporation of Biologically Active Ingredient Gallic Acid Into Nano-scale Lipid Vesicles
title_short Incorporation of Biologically Active Ingredient Gallic Acid Into Nano-scale Lipid Vesicles
title_sort incorporation of biologically active ingredient gallic acid into nano scale lipid vesicles
url https://www.cetjournal.it/index.php/cet/article/view/13409
work_keys_str_mv AT nikakucuk incorporationofbiologicallyactiveingredientgallicacidintonanoscalelipidvesicles
AT matejaprimozic incorporationofbiologicallyactiveingredientgallicacidintonanoscalelipidvesicles
AT zeljkoknez incorporationofbiologicallyactiveingredientgallicacidintonanoscalelipidvesicles
AT majaleitgeb incorporationofbiologicallyactiveingredientgallicacidintonanoscalelipidvesicles